Breaking News

UBM Appoints Group Director

By Kristin Brooks | January 10, 2014

Kilbee to head strategic development of event brands

Chris Kilbee has been appointed group director of UBM Pharma Portfolio CPhI, part of UBM Live. Mr. Kilbee will be responsible for the strategic development and delivery of event brands CPhI, ICSE, Inno-Pack and P-MEC, held in Europe, China, India, Japan, Russia, Turkey, South America and South-East Asia, and digital solutions including CPhI Online and CPhI Pharma Evolution.
 
Mr. Kilbee is an experienced business leader who has worked across a number of different areas at UBM, most recently running a media and events business based in London. Chris has overseen the launch of CPhI Istanbul, a new event starting in 2014, and the completion of the company’s first Annual Industry Report.
 
Mr. Kilbee said, “I am delighted to be taking on this position and overseeing the Pharma portfolio at UBM Live. It is our vision to widen CPhI’s pharma portfolio across new and diverse geographies and platforms where we see opportunities emerging, delivering new services that help to connect the pharma community.”
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks